Market Research International

Global Array Instruments Market 2015-2019

Press Release   •   Aug 11, 2015 03:09 EDT

About array instruments
An array is the technology used in laboratories that quantitatively and simultaneously monitors the expression of thousand genes. The high-throughput approach of microarrays help locate mutations in genotype, measure and detect gene expressions at the mRNA or at the protein level, and locate chromosomal expressions. They work on basic aspects such as hybridization, coupling biomolecules to a platform, sample preparation for detection, data analysis, and scanning. Over the years, array instruments have helped in refining molecular biology, cell biology, genetics, and molecular pathology; synthesizing or sequencing nucleic acids; and accelerating drug discovery processes.
The report's analysts forecast the global array instruments market to grow at a CAGR of 12.48 % over the period 2014-2019.
Covered in this report
The global array instruments market can be divided into three segments: DNA microarrays, protein microarrays, and others including tissue microarrays and cell microarrays. This report covers the present scenario and the growth prospects of the global array instruments market for the period 2015-2019. To calculate the market size, the report considers revenue generated from sales of three applications used by life sciences companies, R&D institutes, and diagnostic laboratories.
This report, Global Array Instruments Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the global array instruments market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key regions
- Americas
Key vendors
- Affymetrix
- Agilent Technologies
- Illumina
Other prominent vendors
- Applied Microarrays
- Arrayit
- Asterand
- AutoGenomics
- AyoxxA
- Bayer Technology Services
- BioCat
- BioChain Institute
- BioGenex Laboratories
- Biolog
- BioM_rieux
- Biometrix Technology
- Bio-Rad Laboratories
- Cancer Genetics
- Cepheid
- CombiMatrix
- EMD Millipore
- Exiqon
- Fluidigm
- Gamida for Life Group
- GE Healthcare
- Genentech
- Grace Bio-Labs
- Great Basin
- InDevR
- Laboratory Corporation of America Holdings
- LC Sciences
- Luminex
- Meso Scale Diagnostics
- Mingyuan Medicare Development Company
- Novus Biologicals (a Bio-Techne company)
- OncoCyte
- OriGene Technologies
- Orla Protein Technologies
- Oxford Gene Technology
- Partek
- Pepscan
- Perkin Elmer
- Phalanx Biotech Group
- ProteoGenix
- Qiagen
- RayBiotech
- Retrogenix
- Takara Bio
- Tecan
- Theranostic Health
- Thermo Fisher Scientific
- US Biomax
- Veredus Laboratories
- Zyagen
Market driver
- Growing importance of microarrays in therapeutics
- For a full, detailed list, view our report
Market challenge
- Lack of expertise and data management issues
- For a full, detailed list, view our report
Market trend
- Advances in personalized medicines
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Market Research International is a leading distributor of PREMIUM market research reports.